Your browser doesn't support javascript.
loading
Structurally modulated codelivery of siRNA and Argonaute 2 for enhanced RNA interference.
Li, Jiahe; Wu, Connie; Wang, Wade; He, Yanpu; Elkayam, Elad; Joshua-Tor, Leemor; Hammond, Paula T.
Afiliação
  • Li J; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Wu C; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Wang W; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • He Y; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Elkayam E; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Joshua-Tor L; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Hammond PT; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
Proc Natl Acad Sci U S A ; 115(12): E2696-E2705, 2018 03 20.
Article em En | MEDLINE | ID: mdl-29432194
ABSTRACT
Small interfering RNA (siRNA) represents a promising class of inhibitors in both fundamental research and the clinic. Numerous delivery vehicles have been developed to facilitate siRNA delivery. Nevertheless, achieving highly potent RNA interference (RNAi) toward clinical translation requires efficient formation of RNA-induced gene-silencing complex (RISC) in the cytoplasm. Here we coencapsulate siRNA and the central RNAi effector protein Argonaute 2 (Ago2) via different delivery carriers as a platform to augment RNAi. The physical clustering between siRNA and Ago2 is found to be indispensable for enhanced RNAi. Moreover, by utilizing polyamines bearing the same backbone but distinct cationic side-group arrangements of ethylene diamine repeats as the delivery vehicles, we find that the molecular structure of these polyamines modulates the degree of siRNA/Ago2-mediated improvement of RNAi. We apply this strategy to silence the oncogene STAT3 and significantly prolong survival in mice challenged with melanoma. Our findings suggest a paradigm for RNAi via the synergistic coassembly of RNA with helper proteins.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Genética / Complexo de Inativação Induzido por RNA / RNA Interferente Pequeno / Interferência de RNA / Proteínas Argonautas Limite: Animals Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Genética / Complexo de Inativação Induzido por RNA / RNA Interferente Pequeno / Interferência de RNA / Proteínas Argonautas Limite: Animals Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2018 Tipo de documento: Article